EFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDY

Simple item page
dc.conference.dateJUN 12-15, 2019
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorBaraliakos, Xenofon
dc.contributor.authorWitte, Torsten
dc.contributor.authorDe Clerck, Luc
dc.contributor.authorFrediani, Bruno
dc.contributor.authorCollantes-Estevez, Eduardo
dc.contributor.authorKatsifis, Gkikas
dc.contributor.authorVanlunen, Brenda
dc.contributor.authorKleine, Elisabeth
dc.contributor.authorHoepken, Bengt
dc.contributor.authorGoodson, Nicola
dc.contributor.authoraffiliation[Baraliakos, Xenofon] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany
dc.contributor.authoraffiliation[Witte, Torsten] Hannover Med Sch, Hannover, Germany
dc.contributor.authoraffiliation[De Clerck, Luc] Antwerp Univ Hosp, Antwerp, Belgium
dc.contributor.authoraffiliation[Frediani, Bruno] Univ Siena, Siena, Italy
dc.contributor.authoraffiliation[Collantes-Estevez, Eduardo] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Katsifis, Gkikas] Naval Hosp Athens, Athens, Greece
dc.contributor.authoraffiliation[Vanlunen, Brenda] UCB Pharma, Raleigh, NC USA
dc.contributor.authoraffiliation[Kleine, Elisabeth] UCB Pharma, Monheim, Germany
dc.contributor.authoraffiliation[Hoepken, Bengt] UCB Pharma, Monheim, Germany
dc.contributor.authoraffiliation[Goodson, Nicola] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
dc.contributor.funderUCB Pharma
dc.date.accessioned2025-01-07T13:19:47Z
dc.date.available2025-01-07T13:19:47Z
dc.date.issued2019-06-01
dc.identifier.doi10.1136/annrheumdis-2019-eular.1707
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/78/Suppl_2/1811.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25428
dc.identifier.wosID472207105396
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.page.number1811-1811
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleEFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDY
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number78
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía